973 related articles for article (PubMed ID: 19939210)
1. Drugs in the medical treatment of Cushing's syndrome.
Schteingart DE
Expert Opin Emerg Drugs; 2009 Dec; 14(4):661-71. PubMed ID: 19939210
[TBL] [Abstract][Full Text] [Related]
2. Medical treatment of Cushing's syndrome: adrenal-blocking drugs and ketaconazole.
Feelders RA; Hofland LJ; de Herder WW
Neuroendocrinology; 2010; 92 Suppl 1():111-5. PubMed ID: 20829630
[TBL] [Abstract][Full Text] [Related]
3. Medical treatment in Cushing's syndrome: dopamine agonists and cabergoline.
Petrossians P; Thonnard AS; Beckers A
Neuroendocrinology; 2010; 92 Suppl 1():116-9. PubMed ID: 20829631
[TBL] [Abstract][Full Text] [Related]
4. Cushing's syndrome.
Schteingart DE
Endocrinol Metab Clin North Am; 1989 Jun; 18(2):311-38. PubMed ID: 2663477
[TBL] [Abstract][Full Text] [Related]
5. Advances in medical therapies for Cushing's syndrome.
Tritos NA; Biller BM
Discov Med; 2012 Feb; 13(69):171-9. PubMed ID: 22369976
[TBL] [Abstract][Full Text] [Related]
6. [Medical treatment for Cushing's syndrome].
Nishikawa T; Saito J; Omura M
Nihon Rinsho; 2008 Jan; 66(1):186-91. PubMed ID: 18186263
[TBL] [Abstract][Full Text] [Related]
7. Pathophysiology of Cushing's disease.
Fehm HL; Voigt KH
Pathobiol Annu; 1979; 9():225-55. PubMed ID: 225710
[TBL] [Abstract][Full Text] [Related]
8. Mitotane, metyrapone, and ketoconazole combination therapy as an alternative to rescue adrenalectomy for severe ACTH-dependent Cushing's syndrome.
Kamenický P; Droumaguet C; Salenave S; Blanchard A; Jublanc C; Gautier JF; Brailly-Tabard S; Leboulleux S; Schlumberger M; Baudin E; Chanson P; Young J
J Clin Endocrinol Metab; 2011 Sep; 96(9):2796-804. PubMed ID: 21752886
[TBL] [Abstract][Full Text] [Related]
9. Short and long-term responses to metyrapone in the medical management of 91 patients with Cushing's syndrome.
Verhelst JA; Trainer PJ; Howlett TA; Perry L; Rees LH; Grossman AB; Wass JA; Besser GM
Clin Endocrinol (Oxf); 1991 Aug; 35(2):169-78. PubMed ID: 1657460
[TBL] [Abstract][Full Text] [Related]
10. Classic and recent etiologies of Cushing's syndrome: diagnosis and therapy.
Beauregard C; Dickstein G; Lacroix A
Treat Endocrinol; 2002; 1(2):79-94. PubMed ID: 15765624
[TBL] [Abstract][Full Text] [Related]
11. Cushing's disease: current medical therapies and molecular insights guiding future therapies.
Lau D; Rutledge C; Aghi MK
Neurosurg Focus; 2015 Feb; 38(2):E11. PubMed ID: 25639313
[TBL] [Abstract][Full Text] [Related]
12. Evaluation and treatment of Cushing's syndrome.
Nieman LK; Ilias I
Am J Med; 2005 Dec; 118(12):1340-6. PubMed ID: 16378774
[TBL] [Abstract][Full Text] [Related]
13. Acquired prolactin deficiency (APD) after treatment for Cushing's disease is a reliable marker of irreversible severe GHD but does not reflect disease status.
Mukherjee A; Murray RD; Teasdale GM; Shalet SM
Clin Endocrinol (Oxf); 2004 Apr; 60(4):476-83. PubMed ID: 15049963
[TBL] [Abstract][Full Text] [Related]
14. Management of diabetes mellitus in Cushing's syndrome.
Munir A; Newell-Price J
Neuroendocrinology; 2010; 92 Suppl 1():82-5. PubMed ID: 20829624
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological therapy of Cushing's syndrome: drugs and indications.
Díez JJ; Iglesias P
Mini Rev Med Chem; 2007 May; 7(5):467-80. PubMed ID: 17504182
[TBL] [Abstract][Full Text] [Related]
16. Cushing's disease: adrenal steroidogenesis inhibitors.
Pivonello R; Simeoli C; Di Paola N; Colao A
Pituitary; 2022 Oct; 25(5):726-732. PubMed ID: 36036308
[TBL] [Abstract][Full Text] [Related]
17. Therapy of Cushing's syndrome with steroid biosynthesis inhibitors.
Engelhardt D; Weber MM
J Steroid Biochem Mol Biol; 1994 Jun; 49(4-6):261-7. PubMed ID: 8043488
[TBL] [Abstract][Full Text] [Related]
18. ACTH response to corticotropin releasing hormone in Cushing's disease before and after ketoconazole: in vivo and in vitro studies.
Boscaro M; Sonino N; Rampazzo A; Menegus AM; Mantero F
Horm Metab Res Suppl; 1987; 16():60-2. PubMed ID: 2832292
[TBL] [Abstract][Full Text] [Related]
19. Somatostatin and somatostatin receptors in Cushing's disease.
Hofland LJ
Mol Cell Endocrinol; 2008 May; 286(1-2):199-205. PubMed ID: 18221833
[TBL] [Abstract][Full Text] [Related]
20. Medical therapy of Cushing's disease.
Nieman LK
Pituitary; 2002; 5(2):77-82. PubMed ID: 12675504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
